ArticleBlood advances2017

Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib.

Alexander P Bye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.